A Pilot study to evaluate the safety and efficacy of Gunmakudori Mezhugu in the management of Polycystic ovarian syndrome (PCOS).
Phase 2
Completed
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2022/03/041489
- Lead Sponsor
- Central Council for Research in Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 34
Inclusion Criteria
1.Age limit 18 years to 45 years.
2.PCOS women diagnosed by Rotterdam criteria.
3.Presence with Oligomenorrhea or Amenorrhea after negative screening pregnancy test.
4.Hyperandrogenism clinically Hirsutism, Biochemically elevated serum testosterone concentrations.
5.Polycystic ovaries.
Exclusion Criteria
1.Age younger than 18 or older than 45
2.Hyperandrogenism due to other reasons including hyperprolactinemia, thyroid diseases, congenital adrenal hyperplasia, Cushing syndrome etc.
3.Subjects with metabolic, endocrinal disorders and psychiatric illnesses.
4.Not associated with any organic reproductive system abnormalities.
5.Current or previous (within the last 3 months) use of oral contraceptives.
6.Pregnant or suspected to be pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method